Last updated: 1 March 2024 at 5:51pm EST

Dr. Thomas J. Hudson Net Worth

Dr. Thomas J. Hudson biography

Dr. Thomas J. Hudson is the Sr. VP of R&D and Chief Scientific Officer at Abbvie Inc.

How old is Dr Hudson?

Dr Hudson is 59, he's been the Sr. VP of R&D and Chief Scientific Officer of Abbvie Inc since . There are 11 older and 20 younger executives at Abbvie Inc. The oldest executive at Abbvie Inc is Edward Liddy, 73, who is the Independent Director.

What's Dr Hudson's mailing address?

Thomas's mailing address filed with the SEC is North Waukegan Road, North Chicago, Lake County, Illinois, 60044, United States.

Insiders trading at Abbvie Inc

Over the last 12 years, insiders at Abbvie Inc have traded over $324,915,370 worth of Abbvie Inc stock and bought 214,015 units worth $14,446,494 . The most active insiders traders include Richard A Gonzalez, Frederick H Waddell y Glenn F Tilton. On average, Abbvie Inc executives and independent directors trade stock every 22 days with the average trade being worth of $7,529,855. The most recent stock trade was executed by Richard A Gonzalez on 5 August 2024, trading 66,500 units of ABBV stock currently worth $12,403,580.

What does Abbvie Inc do?

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.

Abbvie Inc executives and stock owners

Abbvie Inc executives and other stock owners filed with the SEC include:

Richard Gonzalez,
Chairman of the Board, Chief Executive Officer
Laura Schumacher,
Vice Chairman, External Affairs and Chief Legal Officer
Carlos Alban,
Vice Chairman, Chief Commercial Officer
Michael Severino,
President, Vice Chairman
Robert Michael,
Chief Financial Officer, Senior Vice President
William Chase,
Executive Vice President - Finance and Administration
Richard A. Gonzalez,
Chairman & CEO
Dr. Michael E. Severino,
Vice Chairman & Pres
Laura J. Schumacher,
Vice Chairman of External Affairs, Chief Legal Officer & Corp. Sec.
Timothy Richmond,
Chief Human Resource Officer, Executive Vice President
Robert A. Michael,
Vice Chairman of Fin. & Commercial Operations and CFO
Glenn Tilton,
Lead Independent Director
Robert Alpern,
Independent Director
Edward Rapp,
Independent Director
Brett Hart,
Independent Director
William Burnside,
Independent Director
Roxanne Austin,
Independent Director
Frederick Waddell,
Independent Director
Melody Meyer,
Independent Director
Edward Liddy,
Independent Director
Thomas Freyman,
Independent Director
Rebecca Roberts,
Independent Director
Brian Durkin,
Vice President, Controller
Jeffrey Stewart,
Senior Vice President, U.S. Commercial Operations
Nicholas Donoghoe,
Senior Vice President - Enterprise Innovation
Azita Saleki-Gerhardt,
Executive Vice President - Operations
Henry Gosebruch,
Executive Vice President, Chief Strategy Officer
Scott T. Reents,
Sr. VP & CFO
Jeffrey Ryan Stewart,
Exec. VP & Chief Commercial Officer
Henry O. Gosebruch,
Exec. VP & Chief Strategy Officer
Scott C. Brun M.D.,
VP of Scientific Affairs & Head of AbbVie Ventures
Timothy J. Richmond,
Exec. VP & Chief HR Officer
Elizabeth Shea,
VP of Investor Relations
Dr. Thomas J. Hudson,
Sr. VP of R&D and Chief Scientific Officer
Dr. Azita Saleki-Gerhardt,
Exec. VP of Operations
Thomas A. Hurwich,
VP, Controller
Jennifer L. Davis,
Roy S Roberts,
Director
Laboratories Abbott,
10% owner
John M Leonard,
SVP, Chief Scientific Officer
Elaine K. Sorg,
SVP, US COMMERCIAL OPERATIONS
Perry C Siatis,
EVP, GC AND SECRETARY
Carrie C Strom,
SVP & PRES GLOBAL ALLERG AESTH
Thomas J Hudson,
SVP, CSO, GLOBAL RESEARCH
Scott T Reents,
EVP, CHIEF FINANCIAL OFFICER
Susan E Quaggin,
Kevin K Buckbee,
SVP, CONTROLLER
Roopal Thakkar,
SVP, CMO, GLOBAL THERAPEUTICS